Concepedia

Yu Chen

YC

Statistics

Publications

4

Citations

153

H-Index

4

Active since

2022

Affiliations

Fujian Medical University(Current)

Fujian Provincial Cancer Hospital

Ministry of Education

Peking University Cancer Hospital

Peking University

Yu Chen is an author at Fujian Medical University specializing in oncology, checkpoint inhibitor therapy, and melanoma pharmacotherapy.

ORCID

Publications per year

2022–2024

4

Publications

4

Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer

Zengqing Guo, Yuan Yuan, Chao Chen et al. · npj Precision Oncology · 2022 · 76 citations · Full text

, , +17

Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study

Lili Mao, Meiyu Fang, Yu Chen et al. · Clinical Cancer Research · 2022 · 37 citations · Full text

, , +15

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma

Xiaoting Wei, Zhengyun Zou, Weizhen Zhang et al. · European Journal of Cancer · 2024 · 27 citations

, , +14

Phase Ib study of anlotinib in combination with <scp>anti‐PD‐L1</scp> antibody (<scp>TQB2450</scp>) in patients with advanced acral melanoma

Yu Du, Jie Dai, Lili Mao et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 13 citations

, , +16

1–4 of 4